Anti-HIV activity profile of AMD070, an orally bioavailable CXCR4 antagonist

Dominique Schols; Sandra Claes; Sigrid Hatse; Katrien Princen; Kurt Vermeire; De Clercq Erik; Renato T. Skerlj; Gary Bridger; Gary Calandra

Discussion(0)

No comments yet. Be the first to comment.

Related publications

Article2004

In vitro anti-HIV activity profile of AMD887, a novel CCR5 antagonist, in combination with the CXCR4 inhibitor AMD070

Dominique Schols, Kurt Vermeire, Sigrid Hatse, Katrien Princen, De Clercq Erik, Gary Calandra, Simon P. Fricker, Kim L. Nelson, J Labrecque, David Bogucki, Ya-Shi Zhou, Renato T. Skerlj, Gary Bridger

Article2004

Anti-HIV activity profile of a novel CCR5 inhibitor, AMD887, in combination with the CXCR4 inhibitor AMD070

Dominique Schols, Kurt Vermeire, Sigrid Hatse, Katrien Princen, De Clercq Erik, Gary Calandra, Simon P. Fricker, Kim L. Nelson, J Labrecque, David Bogucki, Ya-Shi Zhou, Renato T. Skerlj, Gary Bridger

Article2003

The anti-HIV activity of the CXCR4 inhibitor AMD3100 is independent of the CXCR4/HIV coreceptor level

Katrien Princen, Sigrid Hatse, Kurt Vermeire, Gary Bridger, Renato T. Skerlj, De Clercq Erik, Dominique Schols

Article2003

The antiviral activity of the CXCR4 antagonist AMD3100 is independent of the cytokine-induced CXCR4/HIV coreceptor expression level

Katrien Princen, Sigrid Hatse, Kurt Vermeire, Gary Bridger, Renato T. Skerlj, De Clercq Erik, Dominique Schols

Article2003

The Antiviral Activity of the CXCR4 Antagonist AMD3100 Is Independent of the Cytokine-Induced CXCR4/HIV Coreceptor Expression Level

Katrien Princen, Sigrid Hatse, Kurt Vermeire, Gary Bridger, Renato T. Skerlj, De Clercq Erik, Dominique Schols